Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112956 · ClinicalTrials.gov registry record
Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2
A clinical trial, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT01112956 is a clinical trial that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 2,500 participants.
The verdict
NCT01112956 has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The purposes of this study are: * To determine the accuracy of commercially available serologic assays in diagnosing patients with herpes simplex virus type 2 (HSV-2); * To assess the sensitivity and specificity of the commerical assays using HSV-2 western blot as the "gold standard" in a diverse patient population; * To develop testing strategies and recommendations for screening asymptomatic populations for HSV-2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112956
The ClinicalTrials.gov registry entry for NCT01112956 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01112956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112956 about?
NCT01112956 is a clinical study titled "Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2". The purposes of this study are: * To determine the accuracy of commercially available serologic assays in diagnosing patients with herpes simplex virus type 2 (HSV-2); * To assess the sensitivity and specificity of the commerical assays using HSV-2 western blot as the "gold standard" in a diverse p...
What is the current status of trial NCT01112956?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2009-07. Estimated completion is 2011-02.
Who is sponsoring clinical trial NCT01112956?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.